Searched for
VYOME BIOSCIENCES
Tata group’s Impetis out-licenses arthritis and autoimmune drugs to VyomeIn a significant move for medical innovation, Impetis Biosciences, a subsidiary of Tata group, has teamed up with Vyome Holdings from the U...- Biopharma Co Vyome gets Rs 154 crore from investorsExisting investors Perceptive Advisors, Romulus Capital and Kalaari Capital also participated in this round.
- Meet the persons of Indian origin who are a picture of American healthWhile Indian IT professionals and entrepreneurs have made a mark in the US, Indian doctors too have notched up some significant achievement...
- Now smaller firms developing antibiotics but will society, politicians accept high prices?As a woman dies in the US from a superbug infection likely caught in India, four domestic companies are taking up the cudgels in the area o...
- Vyome Biosciences gets Rs 93cr in Series C"The company will utilise these funds predominantly to advance the clinical development of its lead product and continue to develop other p...
- Boston’s Romulus Capital picks up Vyome Biosciences in maiden India dealThe investment by venture capital firm, which was founded by Krishna Gupta along with Neil Chheda while still studying at MIT, comes at a t...
- Vyome Bio's acne drug gets USFDA nodBio-pharmaceutical company Vyome Biosciences today said the US Food and Drug Administration (USFDA) has cleared its investigational new dru...
- When ace scientists like Rajesh Gokhale turn rookie entrepreneursScientists of distinction are setting up companies but with a difference — to help solve difficult problems of business and society.
- Are India’s life sciences startups turning a corner?A life sciences or medical product company is yet to make it big anywhere in India, despite a startup culture that is 15 years old.
- Can PM Narendra Modi work his magic on Indian science?At the recent Science Congress, Prime Minister Modi touched upon many pain points, offering to make India a great place to do research.
- Ranjan Pai joins Vyome boardVyome Biosciences today said Managing Director and CEO of Manipal Education & Medical Group Ranjan Pai has joined its Board of Directors.
- Vyome Biosciences closes $8 million funding roundProceeds from the Series B round of funding will be used to drive the completion of critical milestones of US Food and Drug Administration ...
- How lifesciences startups are turning futuristic ideas into successful business venturesLifesciences startups in India are no longer risk averse, developing applications like fuel from seaweed and nanomedicine that shrinks tumo...
- Startups do promising work in drug development, stem cell therapy and advanced diagnosticsDemand for quality healthcare and easier access to capital have led to the launch of many startups working in such areas as new drug develo...
- Eight FDI proposals in pharma for Rs 1,842.55 cr approved: Srikant Kumar JenaGovt said a total of eight proposals amounting to Rs 1,842.55 cr relating to FDI in brownfield pharma sector were approved in August this y...
- Power of Ideas 2012: How made-in-India medical tech startups save lives across bordersSpanning areas such as medical devices, stem cells and next generation drugs, a group of startups is creating breakthrough innovations that...
- Vyome Biosciences raises Rs 18.5 crore venture capital fundsVyome Biosciences has raised Rs 18.50 crore in its Series A round of funding, led by venture capital firm, IndoUS Venture Partners, with pa...
- NRI scientists who turned research into successful businessesNot many Indians in US would risk turning their scientific research into successful businesses. Here is the story of the bravehearts who di...
- Expat scientist-entrepreneurs are relocating to India to offer cost-effective healthcare innovationsGlobal scientists of Indian-origin, who have made path-breaking discoveries in the field of healthcare, are moving to India to test, valida...
Load More
